Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank79
3Y CAGR+34.0%
5Y CAGR+25.5%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+34.0%/yr
vs -33.7%/yr prior
5Y CAGR
+25.5%/yr
Recent acceleration
Acceleration
+67.7pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.75M+12.9%
2024$1.55M+48.2%
2023$1.04M+43.8%
2022$726000.00+1761.5%
2021$39000.00-93.0%
2020$561000.00-73.8%
2019$2.15M-43.1%
2018$3.77M+1343.3%
2017$261000.00-92.5%
2016$3.47M-